A decisive step toward democratizing cancer diagnosis: the global potential of an accessible, AI-powered blood test
International study validates OncoSeek, a low-cost AI blood test for early multi-cancer detection.
Oncologia Brasil
6 min read
October 9, 2025
Highlights
SnackableHealth® |Non-cardiac effects in HELIOS-B trial: gastrointestinal symptoms and quality-of-life signals discussed by Drs. Mike Gibson and Tony Urey
ASCO GU® 2026
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
SnackableHealth® |Non-cardiac effects in HELIOS-B trial: gastrointestinal symptoms and quality-of-life signals discussed by Drs. Mike Gibson and Tony Urey
ASCO GU® 2026
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
Written by Oncologia Brasil
About
Oncologia Brasil is a specialized oncology platform with a team of experts covering all aspects of cancer treatment, providing relevant content and personalized solutions. Its goal is to meet the needs of healthcare professionals, pharmaceutical industries, and patients by offering reliable and up-to-date information to improve cancer understanding and management.